Rocket Lab Stock (RKLB) Hits a Record High After a Landmark $816M Missile-Tracking Satellite Deal: News, Forecasts, and What’s Next (Dec. 20, 2025)

Rocket Lab Stock (RKLB) Hits a Record High After a Landmark $816M Missile-Tracking Satellite Deal: News, Forecasts, and What’s Next (Dec. 20, 2025)

December 20, 2025 — Rocket Lab Corporation (NASDAQ: RKLB) is ending the week with the kind of headline every growth stock dreams about: a record close, a major U.S. national security contract, and renewed investor focus on the company’s longer-term
Luminar Technologies Stock (LAZR) in Focus: Chapter 11, Nasdaq Delisting, and Analyst Forecasts as Volatility Surges (Dec. 20, 2025)

Luminar Technologies Stock (LAZR) in Focus: Chapter 11, Nasdaq Delisting, and Analyst Forecasts as Volatility Surges (Dec. 20, 2025)

December 20, 2025 — Luminar Technologies stock (ticker: LAZR) has entered one of the most extreme—and most misunderstood—phases a public company can experience: trading during an active Chapter 11 bankruptcy process while facing imminent Nasdaq delisting. At the last close
GSK plc Stock News and Forecast (Dec. 20, 2025): TrumpRx Pricing Deal, Exdensur FDA Approval, Buybacks, and Analyst Targets

GSK plc Stock News and Forecast (Dec. 20, 2025): TrumpRx Pricing Deal, Exdensur FDA Approval, Buybacks, and Analyst Targets

GSK plc (LSE: GSK; NYSE: GSK) heads into the weekend with a rare “everything-bagel” mix of catalysts: a new U.S. drug-pricing agreement tied to tariff relief, a fresh FDA approval that could reshape severe-asthma dosing schedules, expanding vaccine indications in
Go toTop